D2I2.
cancer

Essential thrombocythaemia

In hematology, essential thrombocythemia (ET) is a rare blood cancer characterised by the overproduction of (thrombocytes) by megakaryocytes in the bone . It may, albeit rarely, develop into acute myeloid or myelofibrosis. It is one of the blood cancers wherein the bone marrow produces too many white or red blood cells, or platelets.

Underlined words are explained — tap any of them.

Symptoms — what it feels like

  • ·, insomnia, migraines, headache, and dizziness.

Causes — why it happens

  • ·Overproduction of hematopoietic cells, .

How it's found

  • · criteria.

Treatment

  • ·Low-dose aspirin, plateletpheresis, cytoreductive therapy.

Complications

  • ·, transient ischemic attack, acute , Budd-Chiari syndrome.

Outlook

  • ·Median survival is 18 years.
Plain-language summary adapted from Wikipedia. Not medical advice.